Showing results (71-80 of 90) with videos related to

Sort By:
Pageof 9
Circulation. Cardiovascular Imaging|October 18, 2022
Hepatic T1-Time Predicts Cardiovascular Risk in All-Comers Referred for Cardiovascular Magnetic Resonance: A Post-Hoc AnalysisKatharina Mascherbauer, Carolina Donà, Matthias Koschutnik, et al.
European Journal of Clinical Investigation|August 9, 2025
Association between CMR-derived hepatic T1-time, tricuspid regurgitation and survivalKatharina Mascherbauer, Christina Kronberger, Manuel Gruber, et al.
International Journal of Cardiology. Heart & Vasculature|October 23, 2025
Left atrial appendage thrombi despite oral anticoagulation in transthyretin amyloid cardiomyopathy patients undergoing electrical cardioversion for atrial fibrillation or - flutterMichael Poledniczek, Christina Kronberger, Bernhard Gregshammer, et al.
Frontiers in Medicine|September 24, 2025
The 6-min walk test in transthyretin cardiac amyloidosis: prognostic utility put to the real-world testMichael Poledniczek, Anna Grubmüller, Christina Kronberger, et al.
European Heart Journal. Cardiovascular Imaging|November 17, 2021
Tafamidis treatment delays structural and functional changes of the left ventricle in patients with transthyretin amyloid cardiomyopathyRené Rettl, Christopher Mann, Franz Duca, et al.
Heart (British Cardiac Society)|October 30, 2021
Machine learning-derived electrocardiographic algorithm for the detection of cardiac amyloidosisLore Schrutka, Philip Anner, Asan Agibetov, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|August 21, 2023
Reduction in 99mTc-DPD myocardial uptake with therapy of ATTR cardiomyopathyRené Rettl, Raffaella Calabretta, Franz Duca, et al.
Journal of Personalized Medicine|December 24, 2021
Convolutional Neural Networks for Fully Automated Diagnosis of Cardiac Amyloidosis by Cardiac Magnetic Resonance ImagingAsan Agibetov, Andreas Kammerlander, Franz Duca, et al.
European Heart Journal|August 1, 2022
Riociguat in pulmonary hypertension and heart failure with preserved ejection fraction: the haemoDYNAMIC trialTheresa Marie Dachs, Franz Duca, René Rettl, et al.
Journal of Clinical Medicine|December 30, 2025
Coronary Artery Disease in Cardiac Amyloidosis: Prevalence, Clinical Relevance, and Cardiac Magnetic Resonance Imaging FeaturesCarolina Donà, Renè Rettl, Christina Binder-Rodriguez, et al.
Pageof 9